Alzheimer's Disease International

21/09/2026

It's World Alzheimer’s Day!

Around the world, people are coming together to raise awareness of Alzheimer's disease and all types of dementia, challenge stigma and show their support for people living with dementia and their families.

This year's World Alzheimer's Month campaign is focused on one important message:
The Earlier You Know, The More You Can Do: A Dementia Diagnosis Matters.

A diagnosis can provide answers. It can help people access treatment, care and support, make informed decisions and plan for the future.

Yet too many people continue to face barriers to diagnosis, including stigma, fear, lack of awareness and unequal access to healthcare. Today we ask you to help change that.

Talk about dementia. Challenge stigma. Share trusted information. Encourage people with concerns to seek advice. Together, we can help create a world where everyone can actively seek an earlier diagnosis.

The earlier you know, the more you can do.

Join us for our World Alzheimer's Month campaign: https://bit.ly/3UkBuyD

Featured in this post:
Alzheimer's Pakistan, Stichting Alzheimer Curaçao, Feledhetetlen, Lanka Foundation, 台灣失智症協會 Taiwan Alzheimer's Disease Association, Alzheimer Indonesia, Alzheimer Nederland, DeutscheAlzheimerGesellschaft, Alzheimer's South Africa, VI Alzheimer's Association, Alzheimer HONDURAS, Tase Fundacion, WHO, barbados alz association, Ministerio de Salud Chile, Alzheimer's Care Armenia Ալցհայմերի խնամք Հայաստան, HKADA 香港認知障礙症協會, Alzheimer's Disease Association of the Philippines, teuntoebes, Bill Gates, HKADA

21/09/2026

Today on World Alzheimer’s Day, ADI Regional Director for the Asia Pacific, DY Suharya was in Colombo, Sri Lanka, where the Lanka Alzheimer’s Foundation (LAF) were celebrating a momentous milestone of their 25th anniversary.

Around 100 people attended the World Alzheimer’s Day and LAF anniversary celebrations including dementia advocates, the Mayor of Colombo Ms Vraie Balthazar, the co-founder of LAF Lorraine Yu, the current President of LAF Prof Shehan Williams, LAF Board Members Ms Romany Parakrama and Mrs Lakmali Cabral, and WHO Country Rep Dr Rajesh Pandav – who all came together to celebrate LAF’s milestone of 25 years of dementia care and support services for people in their country and community.

As part of the festivities, DY participated in a memory walk with 200 participants on 19 September and further activities this week include a session on “training the trainers” a high-level discussion involving prominent stakeholders, a focus group discussion, in-depth interviews facilitated by experts from the region and recognition of the Lanka Alzheimer’s Foundation activity centre – which is celebrating 15 years of service for people living with dementia.

The momentum is building in Sri Lanka, with all these activities and celebrations taking place with the purpose of raising awareness of dementia, but also with the goal of gathering support for a national dementia plan for Sri Lanka: a plan that can support nearing 300,000 people living with dementia in the country.

’sBiz

21/09/2026

The 2026 World Alzheimer Report is now available: A New Era of Dementia Clinical Trials!

Dementia clinical trials are bringing new opportunities alongside important questions about how we make research more inclusive, accessible and effective to enable emerging and future innovation for dementia treatments.

The 2026 World Alzheimer Report explores key issues including recruitment participation and retention, the importance of global representation, diversification and their impact on inclusive dementia research, and the need to increase awareness and understanding of clinical trials among medical practitioners. The report also explores what clinical trials are and how they work, while sharing personal perspectives and experiences from people involved in clinical research.

By bringing together evidence and lived experiences, the report shines a light on recommendations to ensure the next generation of dementia clinical trials are fit to deliver global innovation for future treatments.

Download the 2026 World Alzheimer Report today: https://bit.ly/4iF82gQ

The 2026 World Alzheimer Report explores the critical and timely topic of dementia clinical trials in an easily-digestible format through essays and case studies. It explores dementia clinical trials from recruitment, to ethics, to current opportunities and challenges, and how they have the unique a...

21/09/2026

This ADI celebrates Lanka Alzheimer's Foundation's 25th anniversary! Lanka Alzheimer's Foundation was founded 2001 and became a member of ADI the same year. Here is to many more years of continued work together and to supporting people living with dementia in !

18/09/2026

This week in Bogotá, ADI Regional Director for the Americas Diego Aguilar, alongside delegates of Alzdecolombia, Colombian researchers and academics, engaged with Senator Norma Hurtado and her team to help strengthen Colombia’s national dementia bill and support its path towards public policy, as part of the Regional Symposium on Brain Health and Dementia, organised by the Neuroscience Programme at Universidad Javeriana.

ADI thanks GBHI for supporting this initiative, and Facundo Manes, Hernando Santamaría-García, Eduar Herrera and all participants for their valuable contributions.

Learn more about ADI's member association for Columbia: https://www.alzint.org/member/asociacion-colombiana-de-alzheimer-y-otras-demencias-alzdecolombia/

18/09/2026

register for our upcoming 2026 World Alzheimer Report launch webinar, where leading experts and report contributors will explore the new era of dementia clinical trials, the human stories behind them, what participation means for a person living with dementia and what these trials could mean for the future of diagnosis, treatment and care.

Register here: https://bit.ly/4xWzDyx

Registrants will receive a download link to the report during the webinar and via email afterward, along with exclusive first access to the event recording, giving registrants the opportunity to revisit the top insights from the discussion.

About the report 📌

The 2026 World Alzheimer Report explores key issues including recruitment participation and retention, the importance of global representation, diversification and their impact on inclusive dementia research, and the need to increase awareness and understanding of clinical trials among medical practitioners. The report also explores what clinical trials are and how they work, while sharing personal perspectives and experiences from people involved in clinical research.

By bringing together evidence and lived experiences, the report shines a light on recommendations to ensure the next generation of dementia clinical trials are fit to deliver global innovation for future treatments.

Register today and join us as we launch the 2026 edition of the World Alzheimer Report. We look forward to welcoming you.

18/09/2026

What happens when you see a doctor about changes in your memory or thinking? A cognitive assessment may be one part of the process. Cognitive assessments can help healthcare professionals understand how someone is thinking, remembering, concentrating and solving problems. They are one of the tools that can contribute to understanding what may be causing changes in cognition.

A cognitive assessment is not, on its own, a diagnosis of dementia. Healthcare professionals may consider the results alongside a person's symptoms, medical history and other assessments to understand the bigger picture.

Knowing what to expect can make the process feel less daunting and may help people feel more confident about raising concerns with medical practitioners.

If you have noticed some of the warning signs of dementia, don't be afraid to ask questions and seek advice.

The earlier you know, the more you can do. A dementia diagnosis matters.

17/09/2026

The launch of the 2026 World Alzheimer Report is just a few days away! This year, the report focuses on dementia clinical trials, coming at a time when clinical trials are transforming the landscape of dementia research. Advances in biomarkers, genetic research, and trial design have contributed to the first disease-modifying treatments for Alzheimer’s and renewed optimism across the wider dementia field.

Ahead of the launch, ADI is sharing another early preview into this year’s report for our global network.

Chapter 3, 'Clinical trials in dementia: Complexity and opportunities,' explores the specific challenges and opportunities that arise when developing and testing new interventions for dementia.

Researchers are increasingly able to identify the condition earlier, recruit more appropriate trial participants, and test interventions with greater precision than ever before. Yet dementia remains one of the most challenging areas of medicine in which to develop new therapies. The biological complexity of different forms of dementia, difficulties in diagnosis, lengthy trial timelines, high costs, and the need to recruit diverse populations all mean that progress can be slow.

This chapter explores how clinical trials are evolving across both pharmacological and non-pharmacological interventions. It also examines efforts to expand research beyond traditional centres in North America and Europe, recognising that globally representative clinical trials are essential if future treatments are to benefit all populations.

Crucially, the chapter asks an increasingly important question as new therapies emerge: what constitutes meaningful success in a clinical trial? For researchers, regulators, and the pharmacological industry, success may be measured through statistical significance; for people living with dementia and their loved ones, preserving independence and maintaining quality of life is often paramount.

To learn more about the complexity and opportunities within dementia clinical trials, register for our World Alzheimer Report 2026 launch webinar: A new era in dementia clinical trials, taking place on 21 September 2026 at 14:00 BST.

Register today! https://bit.ly/4xWzDyx

16/09/2026

¿Sabías que existen 10 señales de alerta comunes de la demencia?

Este , queremos animar a nuestra red global a conocer mejor los síntomas de la demencia, para que las personas y sus familias puedan dar pasos importantes hacia un diagnóstico temprano.

Si tú o alguien cercano ha notado cambios en la memoria, el pensamiento o el comportamiento, consultar con un profesional de la salud puede ser el primer paso.

Aunque recibir un diagnóstico puede generar miedo, saber qué está pasando puede ayudar a comprender mejor lo que está ocurriendo, acceder a tratamiento, atención y apoyo, y tomar decisiones informadas sobre el futuro.

Este Mes Mundial del Alzheimer, puedes consultar el póster de ADI “10 señales de alerta de la demencia”, diseñado para ayudar a reconocer algunos de los signos más comunes, desde problemas de memoria que interfieren con la vida cotidiana hasta dificultades para resolver problemas, comunicarse o cambios en el estado de ánimo y el comportamiento.

El póster está disponible en 10 idiomas.

Consulta los materiales aquí: https://bit.ly/Dementia-Warning-Signs

16/09/2026

Dementia is not a normal part of ageing.

Yet 65% of health and care professionals incorrectly believe that dementia is a normal part of getting older.

This misconception can have serious consequences. When changes in memory, thinking or behaviour are dismissed as a normal part of ageing, people may be less likely to seek medical advice and receive an earlier diagnosis.

This World Alzheimer’s Month, you can access ADI’s '10 Warning Signs of Dementia' poster, designed help people recognise the most common signs, from memory loss that disrupts daily life to challenges with problem-solving, language or changes in mood and behavior. The poster is available in 10 languages.

Access the posters today: https://bit.ly/dementia-warning-signs

Greater awareness among health and care professionals, alongside the wider public, is essential to recognising dementia and supporting people to access the right care.

This World Alzheimer's Month, let's challenge misconceptions about dementia that deny a person living with dementia, their family and their carers the access to available support, whether it is through disease modifying treatments, additional care, post-diagnosis risk reduction and crucial information.

The earlier you know, the more you can do.

Our infographic showing 10 warning signs of dementia.